• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Express Scripts

Anonymous board for Express Scripts
Replies
0
Views
356
anonymous
Replies
1
Views
479
anonymous
Replies
2
Views
833
anonymous
Replies
1
Views
419
anonymous
Replies
1
Views
2K
anonymous
Replies
8
Views
7K
anonymous
Replies
1
Views
2K
anonymous
Replies
0
Views
2K
anonymous
Replies
2
Views
5K
Anonymous
Replies
0
Views
5K
Anonymous
Replies
0
Views
3K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
8
Views
9K
Anonymous
Replies
3
Views
6K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
0
Views
5K
Anonymous